Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Clinic’n’Cell is a French healthtech and research-services company developing and commercializing an "ex vivo clinical trial" approach that links human metabolism with human cell biology to generate rapid, mechanistic human data. The company positions its platform as an animal-free alternative between conventional in vitro testing and full human clinical trials, serving nutrition, nutraceutical, nutricosmetic, cosmetic, and pharmaceutical customers. Its services include protocol design, execution of ex vivo studies, analysis of mechanisms of action, and scientific publication support. Clinic’n’Cell originated from research at INRAE and Université Clermont Auvergne and operates from Clermont-Ferrand, France. Rather than advancing a traditional drug pipeline, it appears to function primarily as a platform/CRO-style business that validates product benefits and mode of action in humans.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Clinic’n’Cell.